Nevro Corp.
NYSE:NVRO
5.79 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 408.518 | 425.174 | 406.365 | 386.905 | 362.048 | 390.255 | 387.289 | 326.674 | 228.504 | 69.606 | 32.573 | 23.5 | 18.15 |
| Cost of Revenue
| 138.99 | 135.114 | 129.998 | 120.863 | 112.146 | 121.905 | 113.965 | 98.981 | 75.433 | 28.12 | 11.278 | 9.473 | 7.527 |
| Gross Profit
| 269.528 | 290.06 | 276.367 | 266.042 | 249.902 | 268.35 | 273.324 | 227.693 | 153.071 | 41.486 | 21.295 | 14.027 | 10.623 |
| Gross Profit Ratio
| 0.66 | 0.682 | 0.68 | 0.688 | 0.69 | 0.688 | 0.706 | 0.697 | 0.67 | 0.596 | 0.654 | 0.597 | 0.585 |
| Reseach & Development Expenses
| 51.511 | 54.418 | 53.065 | 47.665 | 45.6 | 59.017 | 48.459 | 37.56 | 33.729 | 21.382 | 19.824 | 20.345 | 15.659 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 266.608 | 219.712 | 142.423 | 82.471 | 29.777 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 309.769 | 334.704 | 322.138 | 309.311 | 267.154 | 305.812 | 266.608 | 219.712 | 142.423 | 82.471 | 29.777 | 18.833 | 14.094 |
| Other Expenses
| 34.477 | 0.246 | 0.511 | -0.814 | -0.495 | -0.697 | -1.164 | 1.067 | -1.097 | -1.741 | -1.88 | -0.654 | 0.186 |
| Operating Expenses
| 395.757 | 389.368 | 375.203 | 356.976 | 312.754 | 364.829 | 315.067 | 257.272 | 176.152 | 103.853 | 49.601 | 39.178 | 29.753 |
| Operating Income
| -126.229 | -99.308 | -98.836 | -90.934 | -62.852 | -96.479 | -41.743 | -29.579 | -23.081 | -62.367 | -28.306 | -25.151 | -19.13 |
| Operating Income Ratio
| -0.309 | -0.234 | -0.243 | -0.235 | -0.174 | -0.247 | -0.108 | -0.091 | -0.101 | -0.896 | -0.869 | -1.07 | -1.054 |
| Total Other Income Expenses Net
| 13.883 | 1.449 | -1.9 | -19.892 | -19.345 | -5.608 | -6.694 | -5.671 | -7.074 | -3.898 | -1.896 | -0.501 | 0.325 |
| Income Before Tax
| -112.346 | -97.859 | 4.264 | -130.826 | -82.197 | -102.087 | -48.437 | -35.25 | -30.155 | -66.265 | -30.202 | -25.652 | -18.805 |
| Income Before Tax Ratio
| -0.275 | -0.23 | 0.01 | -0.338 | -0.227 | -0.262 | -0.125 | -0.108 | -0.132 | -0.952 | -0.927 | -1.092 | -1.036 |
| Income Tax Expense
| 1.093 | -5.646 | 1.263 | 0.534 | 0.868 | 1.599 | 0.768 | 1.408 | 1.623 | 1.166 | 0.478 | 0.362 | 0.162 |
| Net Income
| -113.439 | -92.213 | 3.001 | -131.36 | -83.065 | -103.686 | -49.205 | -36.658 | -31.778 | -67.431 | -30.68 | -26.014 | -18.967 |
| Net Income Ratio
| -0.278 | -0.217 | 0.007 | -0.34 | -0.229 | -0.266 | -0.127 | -0.112 | -0.139 | -0.969 | -0.942 | -1.107 | -1.045 |
| EPS
| -3.06 | -2.56 | 0.085 | -3.77 | -2.47 | -3.37 | -1.64 | -1.25 | -1.12 | -2.54 | -6.91 | -38.27 | -27.9 |
| EPS Diluted
| -3.06 | -2.56 | 0.085 | -3.77 | -2.47 | -3.37 | -1.64 | -1.25 | -1.12 | -2.54 | -6.91 | -38.27 | -27.9 |
| EBITDA
| -126.229 | -78.31 | 21.023 | -102.399 | -52.205 | -83.356 | -37.856 | -22.841 | -22.044 | -62.919 | -30.09 | -25.104 | -19.091 |
| EBITDA Ratio
| -0.309 | -0.184 | -0.502 | -0.183 | -0.174 | -0.247 | -0.108 | -0.091 | -0.095 | -0.896 | -0.869 | -1.068 | -1.052 |